Surviving Retirement
Followers
Thursday, 19 July 2018
Novartis' MS patent win also a win for Celgene's impending MS drug: analyst
Celgene's drug will now have time to establish itself in the market without generic competition.
from Most popular articles from Medical Marketing and Media https://ift.tt/2mtL52U
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment